Site and tumor type predicts DNA mismatch repair status in cutaneous sebaceous neoplasia
- PMID: 18551751
- DOI: 10.1097/pas.0b013e31815b0cc2
Site and tumor type predicts DNA mismatch repair status in cutaneous sebaceous neoplasia
Abstract
Cutaneous sebaceous neoplasia is known to exhibit a high degree of DNA mismatch repair (MMR) deficiency leading to microsatellite instability and these tumors can be markers of the Muir-Torre syndrome and internal malignancy. Other tumors, such as colonic carcinoma, show tendencies toward particular histologic features and sites of involvement correlating with MMR deficiency. There are few comprehensive studies of unselected cutaneous sebaceous neoplasms. To address this gap in knowledge, we examined 94 sebaceous neoplasms from 92 patients and 17 sebaceous hyperplasia controls using immunohistochemistry for MLH1, MSH2, and MSH6. Our results indicate that MMR deficiency is significantly associated with anatomic location (more frequently in the trunk and extremities as compared with head and neck), tumor type (more often in adenoma compared with carcinoma within the head and neck region), and architecture (keratoacanthomalike). No correlation between cystic change and MMR deficiency was noted. Cutaneous sebaceous neoplasia has tendencies toward certain tumor types and anatomic distribution based on MMR status analogous to that seen in colonic carcinomas and other tumors. These may be helpful indicators for further workup for the Muir-Torre syndrome.
Similar articles
-
Importance of universal mismatch repair protein immunohistochemistry in patients with sebaceous neoplasia as an initial screening tool for Muir-Torre syndrome.Hum Pathol. 2016 Mar;49:1-9. doi: 10.1016/j.humpath.2015.10.005. Epub 2015 Oct 31. Hum Pathol. 2016. PMID: 26826402
-
Clinico-pathological predictors of mismatch repair deficiency in sebaceous neoplasia: A large case series from a single Australian private pathology service.Australas J Dermatol. 2019 May;60(2):126-133. doi: 10.1111/ajd.12958. Epub 2018 Dec 2. Australas J Dermatol. 2019. PMID: 30506759
-
Frequency of microsatellite instability in unselected sebaceous gland neoplasias and hyperplasias.J Invest Dermatol. 2003 May;120(5):858-64. doi: 10.1046/j.1523-1747.2003.12125.x. J Invest Dermatol. 2003. PMID: 12713593
-
Molecular Genetics of Sebaceous Neoplasia.Surg Pathol Clin. 2021 Jun;14(2):273-284. doi: 10.1016/j.path.2021.03.005. Surg Pathol Clin. 2021. PMID: 34023105 Review.
-
Muir-Torre syndrome.Lancet Oncol. 2005 Dec;6(12):980-7. doi: 10.1016/S1470-2045(05)70465-4. Lancet Oncol. 2005. PMID: 16321766 Review.
Cited by
-
Establishment and Characterization of a TP53-Mutated Eyelid Sebaceous Carcinoma Cell Line.Invest Ophthalmol Vis Sci. 2023 Dec 1;64(15):16. doi: 10.1167/iovs.64.15.16. Invest Ophthalmol Vis Sci. 2023. PMID: 38095907 Free PMC article.
-
Looking beyond the surface: Muir Torre syndrome.Arch Clin Cases. 2023 Sep 20;10(3):119-122. doi: 10.22551/2023.40.1003.10255. eCollection 2023. Arch Clin Cases. 2023. PMID: 37736596 Free PMC article.
-
Muir-Torre Syndrome: A Cutaneous Finding Amidst Broader Malignancies.Am J Clin Dermatol. 2023 May;24(3):375-380. doi: 10.1007/s40257-023-00757-9. Epub 2023 Jan 25. Am J Clin Dermatol. 2023. PMID: 36695997 Review.
-
TP53 Abnormalities and MMR Preservation in 5 Cases of Proliferating Trichilemmal Tumours.Dermatopathology (Basel). 2021 May 25;8(2):147-158. doi: 10.3390/dermatopathology8020021. Dermatopathology (Basel). 2021. PMID: 34070291 Free PMC article.
-
Sebaceoma of a Meibomian Gland of the Upper Eyelid.Ocul Oncol Pathol. 2020 Aug;6(4):297-304. doi: 10.1159/000504627. Epub 2020 Jan 22. Ocul Oncol Pathol. 2020. PMID: 33005621 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
